Skip to main content
. 2018 Aug 3;16(4):5214–5222. doi: 10.3892/ol.2018.9264

Figure 2.

Figure 2.

Ten-year overall and disease-free survival of patients with CRC according to PD-L1 expression. The 10-year OS and DFS rates were significantly higher in the high PD-L1 expression group than in the low PD-L1 expression group and low PD-L1 expression was significantly associated with tumor relapse and poor prognosis in stage III CRC. CRC, colorectal cancer.